CML is characterized by the Philadelphia chromosome (Ph+), which consists of the fusion of the Abelson gene (ABL1) from chromosome 9q34 with the breakpoint cluster region (BCR) gene located on chromosome 22q11.2. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.